Skip to content

Clinical trials

Liposarcoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liposarcoma Country / region: France Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20061
20071
20091
20122
20142
20152
20161
20171
20202
20212
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting5
Terminated2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC8
Gustave Roussy, Cancer Campus, Grand Paris2
Institut Bergonié2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Australia and New Zealand Sarcoma Association1
Boehringer Ingelheim1
Centre Hospitalier Universitaire de Nice1
Eli Lilly and Company1
European Paediatric Soft Tissue Sarcoma Study Group1
Grupo Espanol de Investigacion en Sarcomas1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liposarcoma27
Sarcoma14
Leiomyosarcoma11
Fibrosarcoma9
Hemangiosarcoma8
Histiocytoma, Malignant Fibrous8
Sarcoma, Synovial6
Neurofibrosarcoma5
Rhabdomyosarcoma5
Neoplasms4

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.